Precision medicine for rare diseases: The times they are A-Changin'
- 4 March 2022
- journal article
- research article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 63, 102201
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Local modulation of cystic fibrosis conductance regulator: cytoskeleton and compartmentalized cAMP signallingBritish Journal of Pharmacology, 2013
- APC Germline Mutations in Individuals Being Evaluated for Familial Adenomatous PolyposisThe Journal of Molecular Diagnostics, 2013
- CFTR biomarkers: time for promotion to surrogate end-pointEuropean Respiratory Journal, 2012
- Drug repositioning for orphan diseasesBriefings in Bioinformatics, 2011
- Biological and Chemical Approaches to Diseases of Proteostasis DeficiencyAnnual Review of Biochemistry, 2009
- New insights into cystic fibrosis: molecular switches that regulate CFTRNature Reviews Molecular Cell Biology, 2006
- CYSTIC FIBROSIS: GENOTYPIC AND PHENOTYPIC VARIATIONSAnnual Review of Genetics, 1995
- Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosisCell, 1990
- Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cellsNature, 1990
- Righting the wrong proteinNature, 1990